Clinical Targeted Next-Generation Panel Sequencing Reveals MYC Amplification Is a Poor Prognostic Factor in Osteosarcoma.
JCO Precis Oncol
; 7: e2200334, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36996377
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bone Neoplasms
/
Osteosarcoma
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
JCO Precis Oncol
Year:
2023
Document type:
Article
Affiliation country:
Marruecos